Recognized for his leadership and expertise, Dr. Dhar serves as medical director of CHOC Children’s neonatal intensive care unit (NICU), Dr. Dhar specializes in neonatal critical care, with particular interests in cytokines, nitric oxide, extracorporeal membrane oxygenation (ECMO) and high-frequency oscillating ventilation (HFOV) performed at CHOC.
On the forefront of innovative treatments, Dr. Dhar participates in numerous research studies. As the principal investigator in the NICU Tracheal Aspirate Study, Dr. Dhar and his associates evaluate tracheal aspirate leptin and parathyroid hormone-related protein levels in predicting the development of bronchopulmonary dysplasia.
Driven with a passion for better outcomes for neonates and children, Dr. Dhar is a coinvestigator in the multicenter National Children’s study which examines the effects of the environment, as broadly defined to include factors such as air, water, diet, sound, family dynamics, community and cultural influences, and genetics on the growth, development, and health of children from before birth until age 21 years. The goal of the study is to improve the health and well-being of children and contribute to understanding the role various factors have on health and disease.
Dedicated to clinical excellence, Dr. Dhar is board certified in pediatrics and neonatology. Prior to joining CHOC Children’s, Dr. Dhar attended medical school at the Postgraduate Institute of Medical Education and Research in Chandigarh, India. He served his pediatric internship and residency at All India Institute of Medical Sciences in Chandigarh, and Gauhati Medical College in Gauhati. Dr. Dhar completed his fellowship training at the Hospital for Sick Children in Toronto and UC Irvine Medical Center in Orange County.
Highly regarded in his field, Dr. Dhar was voted as one of Orange County’s Top Doctors in consecutive years, and has been recognized as a Physician of Excellence by the Orange County Medical Association for the past 10 years.
Dhar V, Perlman M, Cutz E. Autopsy in Neonatal Intensive Care Units, Utilization Patterns and Associations of Clinicopatholoic Discorances; Journal of Pediatrics 1998; 132: 75-9
Dhar V, Hallman M, Bry K. Interleukin-1 Alpha Upregulates, the Expression of Surfactant Protein A in Rabbit Lung Explants; Biology of the Neonate: 1997; 71: 46-52
Rationale and Potential Use of Cytokines in Prevention and Treatment of Neonatal Sepsis, Clinics in Perinatology, 1998; 25-3: 699-710
Co-investigator in an ICMR funded project, Project No. 3/1/2/29(232)78-RB, entitled “Comparative Study of Schick Test and Indirect Hamagglutination Test for Diphtheria in Children”.
Co-investigator in the National Perinatal Epidemiology Unit (UK) OSIRIS Surfactant Trial 1990: “Open Study of Infants at High Risk of or with Respiratory Insufficiency – the role of Surfactant.
Paper entitled “Immune Status of Children and Response to D.P.T. Vaccination, Published in Indian Journal of Pediatrics, vol. 49:501, 1982
Paper entitled “Plasmapheresis in Acute Guillian Barre Syndrome”, Indian Journal of Pediatrics vol. 20:867, 1983
Paper entitled “Cockington Normogram as a Guide to Phototherapy in the Management of Neonatal Hyperbilirubinemia–Evaluation of Indian Neonates”, Indian Pediatrics vol. 21:229, 1984
Paper entitled “Seip Lawrence Syndrome”, Indian Journal of Pediatrics vol. 49:881, 1982
Paper entitled “Relactation with Metochlorpropomide”, Published in Indian Pediatrics
Epidemiological Survey on the prevalence of Gr. A Streptoccal Vulvovaginitis in Children in a large health district at Romford, United Kingdom
CHOC Children's Specialists
1201 W La Veta Ave
Orange, CA 92868
phone: (714) 509-4373
fax: (714) 509-4072
map & directions